CLOV vs IRD
Clover Health Investments Corp (CLOV) versus Opus Genetics, Inc. (IRD) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Opus Genetics, Inc. (IRD) is a biotechnology company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported IRD revenue for 2024-12-31 was $11.0M. Net income was -$57.5M. Revenue was down 42.3% from 2023-12-31 to 2024-12-31. IRD currently screens at market cap $35.7M.
CLOV currently screens at market cap $1.55B. IRD currently screens at market cap $35.7M.
Not investment advice. Open the CLOV and IRD stock pages for the full models.
Not investment advice.